Why STERIS plc’s (STE) Stock Is Down 9.64%

By Cynthia McLaughlin
August 02, 2026
Featured Tickers:
STE

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate STERIS plc before investing.

In this article, we go over a few key elements for understanding STERIS plc’s stock price such as:

  • STERIS plc’s current stock price and volume
  • Why STERIS plc’s stock price changed recently
  • Upgrades and downgrades for STE from analysts
  • STE’s stock price momentum as measured by its relative strength

About STERIS plc (STE)

Before we jump into STERIS plc’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The company offers cleaning chemistries and sterility assurance products, automated endoscope reprocessing system and tracking products, endoscopy accessories, instruments, washers, and sterilizers and other pieces of capital equipment, as well as equipment used directly in the procedure rooms, including surgical tables, lights, equipment management services, and connectivity solutions; and various preventive maintenance programs, repair services, custom process improvement consulting, and outsourced instrument sterile processing, as well as instrument, devices, and endoscope repair and maintenance services. It also provides process controls and monitoring systems, as well as integrated sterilization equipment, such as accelerators, product handling, and automation; and sterilization modalities, product development, materials testing, and process validation, as well as support services for sterilization equipment and control systems comprising installation, preventive maintenance, updates, repairs, and troubleshooting. In addition, the company offers pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators; and preventive maintenance programs and repair services to support the operation of capital equipment. It serves healthcare providers, medical device and pharmaceutical manufacturers, biopharmaceutical manufacturing facilities, and hospitals. The company was formerly known as New STERIS Limited and changed its name to STERIS plc in November 2015. STERIS plc was founded in 1985 and is headquartered in Mentor, Ohio.

Want to learn more about STERIS plc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about STERIS plc.

Learn More About A+ Investor

STERIS plc’s Stock Price as of Market Close

As of July 31, 2026, 4:00 PM, CST, STERIS plc’s stock price was $228.400.

STERIS plc is down 1.22% from its previous closing price of $231.210.

During the last market session, STERIS plc’s stock traded between $227.670 and $230.130. Currently, there are approximately 98.00 million shares outstanding for STERIS plc.

STERIS plc’s price-earnings (P/E) ratio is currently at 28.8, which is low compared to the Health Care Equipment & Supplies industry median of 31.1. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

STERIS plc Stock Price History

STERIS plc’s (STE) price is currently up 8.47% so far this month.

During the month of July, STERIS plc’s stock price has reached a high of $235.660 and a low of $207.150.

Over the last year, STERIS plc has hit prices as high as $269.440 and as low as $195.140. Year to date, STERIS plc’s stock is down 9.91%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused STERIS plc Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 31, 2026, there was 1 analyst who downgraded STERIS plc’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate STERIS plc’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on STERIS plc’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

STERIS plc’s current valuation based on AAII’s Value Grade is a D, which means it is considered to be Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about STERIS plc (STE) by visiting AAII Stock Evaluator.

Relative Price Strength of STERIS plc

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 31, 2026, STERIS plc has a weighted four-quarter relative price strength of -1.94%, which translates to a Momentum Score of 46 and is considered to be Average.

Want to learn more about how STERIS plc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

STERIS plc Stock Price: Bottom Line

As of July 31, 2026, STERIS plc’s stock price is $228.400, which is down 1.22% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like STERIS plc stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Learn More About A+ Investor

Find New Stock Opportunities With Included With AAII Platinum
O'Neil CAN SLIM Screen: 38.3% Compared to S&P 500
at only 23.3%

Since Inception. Data as of 12/31/2024.




Try AAII Platinum and get full access to
769.3% Stock Superstars Portfolio Total Return Since Inception
Compare to:
710.3% iShare DOW Jones
U.S. Index ETF (IYY)

SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.

Get your free copy of our special report analyzing the tech stocks most likely to outperform the market.

Download the FREE Report Here:

BECOME A MEMBER FOR ONLY $2

Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.